We partner with visionary founders building the next generation of therapeutics, digital health platforms, and R&D infrastructure — from early innovation through clinical validation and beyond.
SPRIM Global Investments occupies a unique position at the intersection of clinical operations and venture capital. Born from decades of hands-on experience in drug and device development, we deploy capital where our operational expertise creates a measurable edge for founders.
We don’t simply write checks — we embed ourselves alongside portfolio companies, providing strategic guidance across regulatory pathways, trial design, commercial launch, and global market access. This operator’s vantage point allows us to identify asymmetric opportunities others overlook.
Decades of experience across the full clinical development lifecycle — from IND-enabling studies through post-market surveillance.
17 offices across the Americas, Asia-Pacific, and Europe provide portfolio companies immediate access to talent, regulators, and markets.
Our CRO and R&D services ecosystem surfaces early-stage opportunities before they reach traditional venture channels.
We accelerate milestones through hands-on support in trial execution, regulatory strategy, and partnership development.
We invest across four interconnected verticals that represent the most consequential opportunities in life sciences innovation today.
Our portfolio spans early-stage ventures to growth-stage companies across Biotechnology, Medicial Devices and Medtech and Pharma R&D Services.
DIGITAL CLINICAL SOLUTION
